The N‐terminal cleavage of cellular prion protein in the human brain

[1]  J. Collinge,et al.  Human Prion Protein with Valine 129 Prevents Expression of Variant CJD Phenotype , 2004, Science.

[2]  T. Onodera,et al.  Alpha‐ and beta‐ cleavages of the amino‐terminus of the cellular prion protein , 2004, Biology of the cell.

[3]  Y. Agid,et al.  Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK , 2003, The Lancet.

[4]  B. Strooper,et al.  The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. , 2001, The Journal of biological chemistry.

[5]  B. Chesebro,et al.  N-terminal Truncation of Prion Protein Affects Both Formation and Conformation of Abnormal Protease-resistant Prion Protein Generatedin Vitro * , 2001, The Journal of Biological Chemistry.

[6]  F. Fahrenholz,et al.  Regulation of the α‐secretase ADAM10 by its prodomain and proprotein convertases , 2001 .

[7]  A. Mangé,et al.  Cleavage of the Amino Terminus of the Prion Protein by Reactive Oxygen Species* , 2001, The Journal of Biological Chemistry.

[8]  C. V. Mering,et al.  Prion Protein Devoid of the Octapeptide Repeat Region Restores Susceptibility to Scrapie in PrP Knockout Mice , 2000, Neuron.

[9]  F. Cohen,et al.  Dominant-Negative Inhibition of Prion Formation Diminished by Deletion Mutagenesis of the Prion Protein , 2000, Journal of Virology.

[10]  J. Hauw,et al.  Neuropathologic variants of sporadic Creutzfeldt–Jakob disease and codon 129 of PrP gene , 2000, Neurology.

[11]  P Brown,et al.  Classification of sporadic Creutzfeldt‐Jakob disease based on molecular and phenotypic analysis of 300 subjects , 1999, Annals of neurology.

[12]  Stanley B. Prusiner,et al.  Nobel Lecture: Prions , 1998 .

[13]  B. Ghetti,et al.  Endogenous proteolytic cleavage of normal and disease-associated isoforms of the human prion protein in neural and non-neural tissues. , 1998, The American journal of pathology.

[14]  S. Prusiner,et al.  Molecular biology and pathogenesis of prion diseases. , 1996, Trends in biochemical sciences.

[15]  G. Siest,et al.  Apolipoprotein E is highly susceptible to oxidation by myeloperoxidase, an enzyme present in the brain , 1996, Neuroscience Letters.

[16]  D. Teplow,et al.  Truncated Forms of the Human Prion Protein in Normal Brain and in Prion Diseases (*) , 1995, The Journal of Biological Chemistry.

[17]  D. Harris,et al.  A prion protein cycles between the cell surface and an endocytic compartment in cultured neuroblastoma cells. , 1993, The Journal of biological chemistry.

[18]  P Brown,et al.  Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. , 1992, Science.

[19]  John Collinge,et al.  Homozygous prion protein genotype predisposes to sporadic Creutzfeldt–Jakob disease , 1991, Nature.

[20]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[21]  F. Fahrenholz,et al.  Regulation of the alpha-secretase ADAM10 by its prodomain and proprotein convertases. , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.